Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes

被引:90
作者
Cabarrocas, J
Bauer, J
Piaggio, E
Liblau, R
Lassmann, H
机构
[1] Univ Vienna, Brain Res Inst, Div Neuroimmunol, A-1090 Vienna, Austria
[2] Hop La Pitie Salpetriere, INSERM, U546, Paris, France
[3] Hop La Pitie Salpetriere, Immunol Lab, Paris, France
关键词
cytotoxic T cell; CD8; MHC class I; brain inflammation; immune surveillance; central nervous system;
D O I
10.1002/eji.200323492
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytotoxic CD8(+) T cells are abundantly present in human virus-induced or putative autoimmune diseases of the central nervous system (CNS). Their direct role in the induction of inflammatory brain damage is, however, poorly understood. We have studied CD8(+) T cell-mediated brain inflammation by transferring MHC class I-restricted hemagglutinin (HA)-reactive T cells from a TCR transgenic mouse line into transgenic mice, which express HA in astrocytes. We show that activated CD8(+) T cells alone can induce monophasic brain inflammation in immunocompetent recipient animals. Similar to previous studies, involving transfer of CD4(+) cells, brain inflammation peaks after 5-7 days and then declines. The pathology of brain inflammation, however, differs fundamentally from that induced by CD4(+) cells. The inflammatory reaction is dominated by T cells and activated microglia in the virtual absence of hematogenous macrophages. This is associated with exquisitely specific destruction of antigen-containing astrocytes in the absence of any bystander damage of myelin, oligodendrocytes or neurons. Furthermore, in contrast to CD4(+) T cells, some CD8(+) cells accumulate in the brain and activate microglia in recipient animals, even in the absence of the specific antigen in the CNS. These data indicate that CD8(+) T cells are prime candidates for immune surveillance of the CNS.
引用
收藏
页码:1174 / 1182
页数:9
相关论文
共 44 条
  • [41] Capability of SART3109-118 peptide to induce cytotoxic T lymphocytes from prostate cancer patients with HLA class I-A11,-A31 and-A33 alleles
    Mohamed, Elnisr Rashed
    Naito, Masayasu
    Terasaki, Yasunobu
    Niu, Yamei
    Gohara, Shojiro
    Komatsu, Nobukazu
    Shichijo, Shigeki
    Itoh, Kyogo
    Noguchi, Masanori
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (02) : 529 - 536
  • [42] Involvement of MHC class I molecule and ICAM-1 in the enhancement of adhesion and cytotoxic susceptibility to immune effector cells of tumor cells transfected with the interleukin (IL)-2, IL-4 or IL-6 gene
    Cao, XT
    Chen, GY
    He, L
    Zhang, WP
    Yu, YZ
    Wang, JL
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1997, 123 (11-12) : 602 - 608
  • [43] Involvement of MHC class I molecule and ICAM-1 in the enhancement of adhesion and cytotoxic susceptibility to immune effector cells of tumor cells transfected with the interleukin (IL)-2, IL-4 or IL-6 gene
    Xuetao Cao
    Guoyou Chen
    Long He
    Weiping Zhang
    Yizhi Yu
    Jianli Wang
    Journal of Cancer Research and Clinical Oncology, 1997, 123 : 602 - 608
  • [44] Introduction of the interferon gamma gene into mouse T lymphoma cells with low MHC class I-expression results in selective induction of H-2D(k) and concomitant enhanced metastasis
    Geldhof, AB
    VandenDriessche, T
    Opdenakker, G
    DeBaetselier, P
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1996, 42 (06) : 329 - 338